CELLCEPT Side Effects

7022465-1 | Iga Nephropathy
on Sep 27, 2010 Male patient from JAPAN , 43 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: iga nephropathy. Cellcept dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with TACROLIMUS (Dose Form: Peroral Agent, Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE (Note: Dosage Is Uncertain.) (View Methylprednisolone Review and Methylprednisolone Label ).

7022457-2 | Acute Myeloid Leukaemia
Patient was taking Cellcept (View Usage). Patient had the following side effects: acute myeloid leukaemia on Sep 21, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with prophylaxis against graft versus host disease and. Cellcept dosage: Dosge Uncertain. During the same period patient was treated with TACROLIMUS (Dosage Uncertain) (View Tacrolimus Review and Tacrolimus Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

7022454-7 | Acute Myeloid Leukaemia
Adverse event was reported on Sep 21, 2010 by a Female patient taking Cellcept (View Usage) (Dosage: Note: Dosage Is Uncertain.) was diagnosed with graft versus host disease and. Location: JAPAN , 61 years of age, After Cellcept was administered, patient had the following side effects: acute myeloid leukaemia. During the same period patient was treated with TACROLIMUS (Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

7022444-4 | Polyuria
on Sep 23, 2010 Male patient from GERMANY , 30 years of age, weighting 220.5 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: polyuria. Cellcept dosage: . During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), PROGRAF (View Prograf Review and Prograf Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.


7018216-7 | Multi-organ Failure
on Sep 21, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with graft versus host disease and was treated with Cellcept (View Usage). Patient had the following side effects: multi-organ failure. Cellcept dosage: Dosage Is Uncertain. During the same period patient was treated with TACROLIMUS (Dosage Is Uncertain) (View Tacrolimus Review and Tacrolimus Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

7018185-X | Acute Myeloid Leukaemia
Patient was taking Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: acute myeloid leukaemia on Sep 21, 2010 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with graft versus host disease and. Cellcept dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with TACROLIMUS (Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

7018179-4 | Acute Myeloid Leukaemia
Adverse event was reported on Sep 21, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: Note: Dosage Is Uncertain.) was diagnosed with graft versus host disease and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. During the same period patient was treated with TACROLIMUS (Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

7014747-4 | Iga Nephropathy
on Sep 15, 2010 Male patient from JAPAN , 43 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient had the following side effects: iga nephropathy. Cellcept dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with TACROLIMUS (Dose Form: Peroral Agent, Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE (Note: Dosage Is Uncertain.) (View Methylprednisolone Review and Methylprednisolone Label ).

7014640-7 | Rhabdoid Tumour Of The Kidney
on Sep 17, 2010 Male patient from JAPAN , 30 years of age, was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: rhabdoid tumour of the kidney. Cellcept dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

7012677-5 | Intestinal Obstruction
Patient was taking Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 48 years of age, was diagnosed with prophylaxis against transplant rejection and. Cellcept dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with PREDNISOLONE (Dose Form: Uncertainty) (View Prednisolone Review and Prednisolone Label ), TACROLIMUS (Dose Form: Uncertainty, Note: Dosage Is Uncertain) (View Tacrolimus Review and Tacrolimus Label ), BASILIXIMAB (Note: Dosage Is Uncertain) (View Basiliximab Review and Basiliximab Label ).

7009868-6 | Abdominal Pain, Abdominal Pain Upper, Anaemia, Asthenia, Cytomegalovirus Infection, Gastric Disorder, Malaise, Rash Macular, Transplant Rejection
Adverse event was reported on Sep 16, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: Frequency: 2000 Mgxday) was diagnosed with transplant and. Location: POLAND , 29 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, anaemia, asthenia, cytomegalovirus infection (What is cytomegalovirus infection?), gastric disorder, malaise, rash macular, transplant rejection. During the same period patient was treated with CYMEVENE (View Cymevene Review and Cymevene Label ), VALCYTE (View Valcyte Review and Valcyte Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

7009848-0 | Laryngeal Granuloma
on Sep 13, 2010 Female patient from UNITED KINGDOM , weighting 164.7 lb, was diagnosed with vasculitis (What is vasculitis?) and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: laryngeal granuloma. Cellcept dosage: Frequency Of Dosing Increased 1 Gm Twice A Day (bd) To Tds Three Times A Day. Patient was hospitalized.

7005466-9 | Malacoplakia Gastrointestinal, Transplant Rejection
on Sep 13, 2010 Male patient from UNITED STATES , 45 years of age, was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: malacoplakia gastrointestinal, transplant rejection. Cellcept dosage: Converted To Enteric Coated Mycophenolic Acid.. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

7001273-1 | Diarrhoea, Infection, Melaena, Multi-organ Failure, Renal Failure, Thrombotic Microangiopathy
Patient was taking Cellcept (View Usage). Patient had the following side effects: diarrhoea, infection (What is infection?), melaena, multi-organ failure, renal failure, thrombotic microangiopathy on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with prophylaxis against transplant rejection and. Cellcept dosage: . During the same period patient was treated with CYCLOSPORINE (Dose Uncertain) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (Note: 1mg/kg1 2mg/kg) (View Methylprednisolone Review and Methylprednisolone Label ), TACROLIMUS (Dose Uncertain) (View Tacrolimus Review and Tacrolimus Label ), PENTOSTATIN (Dose Uncertain) (View Pentostatin Review and Pentostatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), BUSULFAN (View Busulfan Review and Busulfan Label ).

7001101-4 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Focal Segmental Glomerulosclerosis, Renal Disorder
Adverse event was reported on Sep 10, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: Dose Increased.) was diagnosed with renal transplant and. Location: JAPAN , weighting 154.3 lb, After Cellcept was administered, patient had the following side effects: epstein-barr virus associated lymphoproliferative disorder, focal segmental glomerulosclerosis, renal disorder. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), MEDROL (View Medrol Review and Medrol Label ), HERBESSER (View Herbesser Review and Herbesser Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), PERSANTIN (View Persantin Review and Persantin Label ).

6980359-1 |
on Sep 10, 2010 Male patient from CHINA , 59 years of age, was diagnosed with renal transplant and was treated with Cellcept (View Usage). . Cellcept dosage: . During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ).

6973204-1 | Myopathy, Photosensitivity Reaction
on Sep 01, 2010 Female patient from PORTUGAL , 50 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Cellcept (View Usage). Patient had the following side effects: myopathy, photosensitivity reaction. Cellcept dosage: Dose Reported As: 1g Each 12 Hours. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6973169-2 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Focal Segmental Glomerulosclerosis, Renal Disorder
Patient was taking Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: epstein-barr virus associated lymphoproliferative disorder, focal segmental glomerulosclerosis, renal disorder on Aug 31, 2010 from JAPAN Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with renal transplant and. Cellcept dosage: Dose Increased.. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MEDROL (View Medrol Review and Medrol Label ), HERBESSER (View Herbesser Review and Herbesser Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), PERSANTIN (View Persantin Review and Persantin Label ).

6968846-3 | Abdominal Discomfort, Diarrhoea
Adverse event was reported on Sep 03, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: 500mg 3 Bid Oral) was diagnosed with lupus nephritis and. Location: UNITED STATES , 67 years of age, weighting 184.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, diarrhoea.

6968468-4 | Rhabdoid Tumour Of The Kidney
on Aug 25, 2010 Male patient from JAPAN , 30 years of age, was treated with Cellcept (View Usage). Patient had the following side effects: rhabdoid tumour of the kidney. Cellcept dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6968341-1 | Hypokalaemia, Hyponatraemia, Motor Dysfunction
on Aug 26, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with lewis-sumner syndrome and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: hypokalaemia, hyponatraemia, motor dysfunction. Cellcept dosage: . During the same period patient was treated with RASILEZ (Form: Coated Tablet) (View Rasilez Review and Rasilez Label ), IPERTEN (View Iperten Review and Iperten Label ), KARDEGIC (Form: Powder For Oral Solution) (View Kardegic Review and Kardegic Label ), PRAVASTATIN (Derug:pravastatine Sodique) (View Pravastatin Review and Pravastatin Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ). Patient was hospitalized.

6964065-5 | Hip Fracture, Parathyroid Disorder
Patient was taking Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: hip fracture, parathyroid disorder (What is parathyroid disorder?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 170.0 lb, was diagnosed with renal transplant and. Cellcept dosage: 500 Mg In Morning. During the same period patient was treated with MYCOPHENOLATE MOFETIL (500 M At Nite) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6958489-X | Hypoacusis
Adverse event was reported on Jun 25, 2010 by a Female patient taking Cellcept (View Usage) (Dosage: ) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , weighting 133.4 lb, Patient had the following side effects: hypoacusis. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), AMPHETAMINE SULFATE (View Amphetamine Sulfate Review and Amphetamine Sulfate Label ), PROTONIX (View Protonix Review and Protonix Label ), VICODIN ES (View Vicodin Es Review and Vicodin Es Label ), XANAX (View Xanax Review and Xanax Label ).

6958410-4 | Bone Marrow Necrosis
on Oct 14, 2009 Female patient from JAPAN , 44 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: bone marrow necrosis. Cellcept dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6958385-8 | Dehydration, Diarrhoea, Epstein-barr Viraemia, Hyperkalaemia, Hyperuricaemia, Renal Vein Thrombosis, Vena Cava Thrombosis
on Jan 13, 2010 Female patient from JAPAN , child 2 years of age, was diagnosed with renal transplant and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, epstein-barr viraemia, hyperkalaemia, hyperuricaemia, renal vein thrombosis, vena cava thrombosis. Cellcept dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), BASILIXIMAB (View Basiliximab Review and Basiliximab Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ANTIEPILEPTIC (View Antiepileptic Review and Antiepileptic Label ), ANTICOAGULANT (View Anticoagulant Review and Anticoagulant Label ).

6958378-0 | Mycobacterium Kansasii Pneumonia
Patient was taking Cellcept (View Usage). Patient had the following side effects: mycobacterium kansasii pneumonia on Oct 30, 2009 from JAPAN Additional patient health information: Male patient , 54 years of age, was diagnosed with chronic graft versus host disease and. Cellcept dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (Route Intravenous) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), MEDROL (View Medrol Review and Medrol Label ).

6938803-1 | Transplant Failure
Adverse event was reported on Aug 13, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 259.0 lb, After Cellcept was administered, patient had the following side effects: transplant failure. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ).

6938781-5 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Focal Segmental Glomerulosclerosis
on Aug 17, 2010 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with renal transplant and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus associated lymphoproliferative disorder, focal segmental glomerulosclerosis. Cellcept dosage: Dose Increased.. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MEDROL (View Medrol Review and Medrol Label ), HERBESSER (View Herbesser Review and Herbesser Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), PERSANTINE (View Persantine Review and Persantine Label ).

6936537-0 | Myocardial Ischaemia
on Aug 10, 2010 Male patient from JAPAN , 48 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient had the following side effects: myocardial ischaemia. Cellcept dosage: Note: Dosage Is Uncertain. During the same period patient was treated with CYCLOSPORINE (Dose Form: Uncertainty) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (Dose Form: Uncertainty) (View Methylprednisolone Review and Methylprednisolone Label ), BASILIXIMAB (Dose Form: Uncertainty) (View Basiliximab Review and Basiliximab Label ), TACROLIMUS (Dose Form: Uncertainty) (View Tacrolimus Review and Tacrolimus Label ), ADRENAL COMPLEX (Note: Dosage Is Uncertain) (View Adrenal Complex Review and Adrenal Complex Label ).

6932307-8 | Heart Transplant Rejection
Patient was taking Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: heart transplant rejection on Aug 11, 2010 from FRANCE Additional patient health information: Male patient , 22 years of age, . Cellcept dosage: .

6932278-4 | Bone Marrow Oedema
Adverse event was reported on Aug 03, 2010 by a Female patient taking Cellcept (View Usage) (Dosage: Dose Reduced) was diagnosed with immunosuppression and. Location: UNITED KINGDOM , 52 years of age, Patient experienced the following unwanted or unexpected effects: bone marrow oedema. During the same period patient was treated with SIROLIMUS (Dose Was Decreased Gradually.) (View Sirolimus Review and Sirolimus Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), BASILIXIMAB (View Basiliximab Review and Basiliximab Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ).

6921068-4 | Transplant Rejection
on Jul 30, 2010 Male patient from UNITED STATES , 35 years of age, weighting 150.6 lb, was treated with Cellcept (View Usage). Patient had the following side effects: transplant rejection. Cellcept dosage: . During the same period patient was treated with DILATREND (View Dilatrend Review and Dilatrend Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), TENORMIN (View Tenormin Review and Tenormin Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6886748-8 | Colitis Ulcerative, Glucose Tolerance Impaired, Renal Impairment
on Jul 14, 2010 Female patient from JAPAN , child 9 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: colitis ulcerative, glucose tolerance impaired, renal impairment. Cellcept dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with TACROLIMUS (Dose Form: Peroral Agent, Note: Dosage Is Uncertain.) (View Tacrolimus Review and Tacrolimus Label ), ADRENAL COMPLEX (View Adrenal Complex Review and Adrenal Complex Label ).

6879860-0 | Blood Bilirubin Increased, Dactylitis, Dry Mouth, Dry Skin, Lower Extremity Mass, Nasal Dryness, Paronychia, Skin Exfoliation, Skin Fissures
Patient was taking Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, dactylitis, dry mouth, dry skin, lower extremity mass, nasal dryness, paronychia, skin exfoliation, skin fissures on Jul 14, 2010 from CHINA Additional patient health information: Male patient , 53 years of age, weighting 154.3 lb, was diagnosed with liver transplant (What is liver transplant?), hepatic neoplasm malignant, prophylaxis and. Cellcept dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), PROGRAF (View Prograf Review and Prograf Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ).

6862712-X | Cerebrovascular Accident, Lung Infection
Adverse event was reported on Jul 20, 2010 by a Female patient taking Cellcept (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: CHINA , 57 years of age, Patient had the following side effects: cerebrovascular accident, lung infection. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6860590-6 | Transplant Rejection
on Jul 09, 2010 Female patient from ALBANIA , 19 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: transplant rejection. Cellcept dosage: .

6848391-6 | Acute Abdomen, Ileus Paralytic
on Jul 09, 2010 Female patient from AUSTRIA , 24 years of age, weighting 132.3 lb, was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: acute abdomen, ileus paralytic. Cellcept dosage: .

6848380-1 | Abdominal Pain, Cardiac Arrest, Hyperhidrosis
Patient was taking Cellcept (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac arrest (What is cardiac arrest?), hyperhidrosis on Jul 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Cellcept dosage: .

6848366-7 | Incisional Hernia
Adverse event was reported on Jul 09, 2010 by a Male patient taking Cellcept (View Usage) (Dosage: ) was diagnosed with immunosuppression, prophylaxis and. Location: GERMANY , weighting 185.2 lb, After Cellcept was administered, patient had the following side effects: incisional hernia. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ). Patient was hospitalized.

6840048-0 | Cytomegalovirus Test Positive, Disseminated Intravascular Coagulation, Haemolytic Anaemia
on Jun 30, 2010 Female patient from JAPAN , 46 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus test positive, disseminated intravascular coagulation, haemolytic anaemia. Cellcept dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), SIMULECT (View Simulect Review and Simulect Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), PIPERACILLIN SODIUM (Note: Dosage Is Uncertain.) (View Piperacillin Sodium Review and Piperacillin Sodium Label ).

6836143-2 | Myocardial Ischaemia
on Jun 30, 2010 Male patient from JAPAN , 48 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient had the following side effects: myocardial ischaemia. Cellcept dosage: . During the same period patient was treated with CICLOSPORIN (Dose Form: Uncertainty) (View Ciclosporin Review and Ciclosporin Label ), METHYLPREDNISOLONE (Dose Form: Uncertainty) (View Methylprednisolone Review and Methylprednisolone Label ), BASILIXIMAB (Dose Form: Uncertainty) (View Basiliximab Review and Basiliximab Label ), TACROLIMUS (Dose Form: Uncertainty) (View Tacrolimus Review and Tacrolimus Label ).

6836123-7 | Diffuse Large B-cell Lymphoma, Focal Segmental Glomerulosclerosis
Patient was taking Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: diffuse large b-cell lymphoma, focal segmental glomerulosclerosis on Jun 30, 2010 from JAPAN Additional patient health information: Male patient , 30 years of age, was diagnosed with renal transplant and. Cellcept dosage: Dose Increased.. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6836095-5 | Cytomegalovirus Colitis, Pancytopenia, Pulmonary Alveolar Haemorrhage, Rectal Perforation
Adverse event was reported on Jul 06, 2010 by a Female patient taking Cellcept (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus, cytomegalovirus infection (What is cytomegalovirus infection?), infection prophylaxis and. Location: JAPAN , weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: cytomegalovirus colitis, pancytopenia, pulmonary alveolar haemorrhage, rectal perforation. During the same period patient was treated with DENOSINE (Dose Form: Uncertainty, Note: Dosage Is Uncertain.) (View Denosine Review and Denosine Label ), ITRIZOLE (Dose Form: Peroral Liquid Preparation) (View Itrizole Review and Itrizole Label ), ADRENAL COMPLEX (View Adrenal Complex Review and Adrenal Complex Label ), ALLOID G (Dose Form: Peroral Liquid Preparation) (View Alloid G Review and Alloid G Label ), DOGMATYL (Dose Form: Minute Grain) (View Dogmatyl Review and Dogmatyl Label ), PREDONINE (Note: 25mg In Morning And 20mg In Daytime) (View Predonine Review and Predonine Label ).

6832090-0 | Acute Respiratory Distress Syndrome, Diarrhoea, Disseminated Intravascular Coagulation, Enterocolitis, Escherichia Infection, Pneumonia, White Blood Cell Count Decreased
on Jun 30, 2010 Male patient from JAPAN , 42 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cellcept (View Usage). Patient had the following side effects: acute respiratory distress syndrome, diarrhoea, disseminated intravascular coagulation, enterocolitis, escherichia infection, pneumonia (What is pneumonia?), white blood cell count decreased. Cellcept dosage: . During the same period patient was treated with TACROLIMUS (Note: Dosage Is Uncertain) (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (Dose Form: Peroral Agent) (View Prednisolone Review and Prednisolone Label ), BREDININ (View Bredinin Review and Bredinin Label ).

6826949-8 | Cerebrovascular Accident, Lung Infection
on Jul 07, 2010 Female patient from CHINA , 57 years of age, was diagnosed with renal transplant and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: cerebrovascular accident, lung infection. Cellcept dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), CICLOSPORIN (View Ciclosporin Review and Ciclosporin Label ). Patient was hospitalized.

6822657-8 | Arthralgia, Muscle Rigidity, Myalgia
Patient was taking Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, muscle rigidity, myalgia on Jun 28, 2010 from PORTUGAL Additional patient health information: Male patient , weighting 231.5 lb, was diagnosed with focal segmental glomerulosclerosis, blood pressure decreased, gout (What is gout?) and. Cellcept dosage: . During the same period patient was treated with ZARATOR (Dose 1 Tablet In The Evening) (View Zarator Review and Zarator Label ), TEVETEN HCT (View Teveten Hct Review and Teveten Hct Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6817330-6 | Disseminated Intravascular Coagulation, Hepatitis Viral, Pneumonia Herpes Viral, Varicella
Adverse event was reported on Jul 08, 2009 by a Male patient taking Cellcept (View Usage) (Dosage: ) . Location: JAPAN , 43 years of age, Patient had the following side effects: disseminated intravascular coagulation, hepatitis viral, pneumonia herpes viral, varicella. During the same period patient was treated with SIMULECT (View Simulect Review and Simulect Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

6817263-5 | Bronchitis
on Jun 24, 2010 Female patient from GERMANY , 51 years of age, weighting 143.3 lb, was diagnosed with bronchitis (What is bronchitis?), hypothyroidism, hyperlipidaemia, prophylaxis, asthma (What is asthma?) and was treated with Cellcept (View Usage). After Cellcept was administered, patient had the following side effects: bronchitis (What is bronchitis?). Cellcept dosage: . During the same period patient was treated with PROGRAF (Number Of Separate Doses: 2) (View Prograf Review and Prograf Label ), AVELOX (Form: Film-coated Tablet) (View Avelox Review and Avelox Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ), LOCOL (View Locol Review and Locol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), VIANI (View Viani Review and Viani Label ). Patient was hospitalized.

6810126-0 | Hypoacusis
on Jun 25, 2010 Female patient from UNITED STATES , weighting 133.4 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Cellcept (View Usage). Patient experienced the following unwanted or unexpected effects: hypoacusis. Cellcept dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), AMPHETAMINE SULFATE (View Amphetamine Sulfate Review and Amphetamine Sulfate Label ), PROTONIX (View Protonix Review and Protonix Label ), VICODIN ES (View Vicodin Es Review and Vicodin Es Label ), XANAX (View Xanax Review and Xanax Label ).

6803332-2 | Attention Deficit/hyperactivity Disorder, Conductive Deafness, Congenital Cytomegalovirus Infection, Developmental Delay, External Auditory Canal Atresia, Failure To Thrive, Foetal Growth Retardation, Hyperbilirubinaemia, Inguinal Hernia
Patient was taking Cellcept (View Usage). Patient had the following side effects: attention deficit/hyperactivity disorder, conductive deafness, congenital cytomegalovirus infection, developmental delay, external auditory canal atresia, failure to thrive, foetal growth retardation, hyperbilirubinaemia, inguinal hernia on Jun 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 2.20 lb, was diagnosed with lupus nephritis and. Cellcept dosage: . During the same period patient was treated with PREDNISONE (Received Throughout Pregnancy At Different Dosages) (View Prednisone Review and Prednisone Label ), LISINOPRIL (Discontinued In Early Pregnancy.) (View Lisinopril Review and Lisinopril Label ), HYDROXYCHLOROQUINE (Discontinued In Early Pregnancy.) (View Hydroxychloroquine Review and Hydroxychloroquine Label ).